Stargardt programs address ABCA4 payload constraints via dual-AAV platforms (VG801, AAVB-039) and explore first ...
Market expansion in med derm cross over: Almirall’s Seysara (sarecycline) won NMPA approval for moderate to severe acne (≥9 years), with China commercial launch targeted for 2026 – relevant to ...
The coming days represent a significant moment for Ocugen, Inc., with the gene therapy developer's annual financial report on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results